These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3304785)

  • 21. Effect of insulin concentration on bioavailability during nasal spray administration.
    Valensi P; Zirinis P; Nicolas P; Perret G; Sandre-Banon D; Attali JR
    Pathol Biol (Paris); 1996 Apr; 44(4):235-40. PubMed ID: 8763584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.
    Freidenberg GR; White N; Cataland S; O'Dorisio TM; Sotos JF; Santiago JV
    N Engl J Med; 1981 Aug; 305(7):363-8. PubMed ID: 7019707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
    Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
    Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
    Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review.
    Tzamaloukas AH; Oreopoulos DG
    Adv Perit Dial; 1991; 7():81-5. PubMed ID: 1680463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of resistance to subcutaneous insulin with implanted insulin infusion pumps].
    Löchli S; Campbell I; Dorenboos H; Paterson KR; Devlin JG; Hagmüller G; Irsigler K
    Dtsch Med Wochenschr; 1988 Sep; 113(36):1390-3. PubMed ID: 3138098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insulin-induced edema in adolescents with type 1 diabetes mellitus].
    Saule H
    Dtsch Med Wochenschr; 1991 Aug; 116(31-32):1191-4. PubMed ID: 1860423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic pregnancy managed with intraperitoneal insulin.
    Fonseca VA; Menon RK; O'Brien PM; Fernando ON; Stephen R; Dandona P
    Diabet Med; 1987; 4(1):74-6. PubMed ID: 2951228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraindividual comparison of pharmacokinetics of insulin after intravenous, portal, subcutaneous and peritoneal administration.
    Fritze K; Fischer U; Freyse EJ; Besch W
    Exp Clin Endocrinol; 1988 Mar; 92(3):297-306. PubMed ID: 3075553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the insulin requirements with an artificial pancreas in gestational diabetes].
    Fernández I; Rodríguez MA; Gutiérrez A; Costa CJ; Sánchez Ramos J; Durán García S
    Med Clin (Barc); 1989 Jun; 93(4):129-33. PubMed ID: 2677545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of subcutaneous and intraperitoneal administration of insulin on the milk intake of suckling lambs.
    Koppel J; Kuchár S; Mozes S; Herzová J; Bodà K
    Horm Metab Res; 1982 Dec; 14(12):631-3. PubMed ID: 6759358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Insulin pharmacokinetics in insulin-dependent diabetics. Mathematical models].
    Beuscart R; Fontaine P; D'Herbomez-Boidein M
    Diabete Metab; 1989; 15(5):233-41. PubMed ID: 2698365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous antihistamine injection is effective to control a local allergic reaction to human insulin.
    Imakado S; Hamada K; Atsumi Y
    Diabetes Res Clin Pract; 2009 Sep; 85(3):e42-3. PubMed ID: 19520450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous insulin resistance successfully circumvented on long term by peritoneal insulin delivery from an implantable pump in four diabetic patients.
    Riveline JP; Vantyghem MC; Fermon C; Brunet C; Gautier JF; Renard E; Charpentier G;
    Diabetes Metab; 2005 Nov; 31(5):496-8. PubMed ID: 16357794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Status of lipid metabolism in diabetes mellitus type 1 depending upon the degree of compensation of carbohydrate metabolism].
    Balabolkin MI; Antonova TI; Allamiiarov BU
    Sov Med; 1988; (4):110-2. PubMed ID: 3043707
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin and heparin challenge tests are useful for choosing an optimal insulin regimen in a case of subcutaneous insulin resistance.
    Nakamura Y; Nagao M; Kobayashi S; Oba T; Shuto Y; Fukuda I; Oikawa S; Sugihara H
    J Diabetes Investig; 2020 Sep; 11(5):1370-1373. PubMed ID: 32267995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous-insulin-resistance syndrome.
    N Engl J Med; 1987 Jan; 316(1):49-51. PubMed ID: 3537795
    [No Abstract]   [Full Text] [Related]  

  • 40. Subcutaneous peritoneal access device for type I diabetic patients nonresponsive to subcutaneous insulin.
    Schade DS; Eaton RP; Warhol RM; Gregory JA; Doberneck RC
    Diabetes; 1982 May; 31(5 Pt 1):470-3. PubMed ID: 7152135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.